Imara completed dosing patients in the IMR-687 Phase 2a clinical trial in patients with SCD during the third quarter of 2020 and plans to report top-line data late in the fourth quarter of 2020 ...

The 110 propellants listed in the Hornady Handbook of Cartridge Reloading Fifth Edition appear in order of burn rate, from fastest to slowest. IMR 7828 is 100th. AA 8700 is 107th.

Imara reports additional pre-clinical and Phase 1 data for lead compound, IMR-687, at the 6th Annual Sickle Cell Therapeutics Conference in New York.